Hormones and MS: Pregnancy, Periods, Menopause

New insights from experts at the University of Colorado Anschutz Medical Campus highlight how hormonal changes across a woman’s life, from menstruation to pregnancy and menopause, can influence disease activity in multiple sclerosis (MS), while also emphasizing that modern treatment strategies are improving outcomes.

MS is diagnosed up to three times more often in women, particularly during their reproductive years. This pattern suggests a strong connection between sex hormones and immune system behavior, though the exact mechanisms are still being studied.

One of the most important findings is that pregnancy appears to reduce MS disease activity, with relapse rates decreasing significantly, especially in the third trimester. However, this protective effect reverses after childbirth, when the risk of relapse can rise sharply. Emerging treatment strategies, including carefully timed therapies before conception, may help reduce this postpartum risk.

Hormonal shifts during menstruation and menopause may also influence symptoms. While menstrual cycles can temporarily worsen existing symptoms (often referred to as “pseudo-relapses”), menopause may amplify fatigue, brain fog, and sleep disturbances overlapping with core MS symptoms.

Overall, advances in treatment and disease management are helping women with MS navigate reproductive decisions with greater confidence and support.